These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6326950)

  • 21. Effect of thyrotropin releasing hormone on U-50,488H-induced pharmacological responses in mice.
    Bhargava HN; Thorat SN
    Brain Res; 1993 Oct; 625(1):120-4. PubMed ID: 8242390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenergic and non-adrenergic cardiovascular effects of thyrotropin-releasing hormone (TRH) in the anaesthetized rabbit.
    Seligsohn EE
    Acta Physiol Scand; 1992 Sep; 146(1):107-17. PubMed ID: 1359733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central glucagon-induced hyperglycemia is mediated by combined activation of the adrenal medulla and sympathetic nerve endings.
    Amir S
    Physiol Behav; 1986; 37(4):563-6. PubMed ID: 3092255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible role of adrenoceptors in the hypothalamic paraventricular nucleus in corticotropin-releasing factor-induced sympatho-adrenomedullary outflow in rats.
    Okada S; Yamaguchi N
    Auton Neurosci; 2017 Mar; 203():74-80. PubMed ID: 28202248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.
    Tanabe M; Tokuda Y; Takasu K; Ono K; Honda M; Ono H
    Br J Pharmacol; 2007 Feb; 150(4):403-14. PubMed ID: 17220907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant interleukin-1 beta inhibits gastric acid secretion by activation of central sympatho-adrenomedullary outflow in rats.
    Yokotani K; Okuma Y; Osumi Y
    Eur J Pharmacol; 1995 Jun; 279(2-3):233-9. PubMed ID: 7556406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyrotropin-releasing hormone (TRH) and circulatory shock.
    McIntosh TK; Faden AI
    Circ Shock; 1986; 18(3):241-58. PubMed ID: 3084122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyrotropin releasing hormone: autonomic effects upon cardiorespiratory function in endotoxic shock.
    Holaday JW; Faden AI
    Regul Pept; 1983 Oct; 7(2):111-25. PubMed ID: 6419292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on thyrotropin-releasing hormone-induced micturition in cats.
    Beleslin DB; Jovanović-Mićić D; Samardzić R; Terzić B
    J Pharm Pharmacol; 1987 Jun; 39(6):474-6. PubMed ID: 2886606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of the pressor effect of centrally administered thyrotropin-releasing hormone under halothane, pentobarbital and flunitrazepam anaesthesia.
    Tanaka H; Okuda C; Sawa T; Mizobe T; Demura H; Miyazaki M
    Acta Anaesthesiol Scand; 1988 Oct; 32(7):535-40. PubMed ID: 3142198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective suppression of pressor and sympathetic responses to centrally infused TRH in hypothyroid rats.
    Buñag RD; Mattila J
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):51-7. PubMed ID: 2459534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of thyrotropin-releasing hormone on myocardial adrenoceptors and dopaminergic receptors following hemorrhagic shock in the rat.
    Liu LM; Chen HS; Hu DY; Lu RQ; Li TX
    Shock; 1995 Jun; 3(6):430-3. PubMed ID: 7656067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyrotropin releasing hormone increases intraocular pressure. Mechanism of action.
    Liu JH; Dacus AC; Bartels SP
    Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2200-8. PubMed ID: 2507469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of thyrotropin-releasing hormone (TRH)-induced defecation in cats.
    Beleslin DB; Jovanović-Micić D; Samardzić R; Terzić B
    Pharmacol Biochem Behav; 1987 Mar; 26(3):639-41. PubMed ID: 3033706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of exocrine pancreatic secretion by cerebral TRH and CGRP: role of VIP, muscarinic, and adrenergic pathways.
    Messmer B; Zimmerman FG; Lenz HJ
    Am J Physiol; 1993 Feb; 264(2 Pt 1):G237-42. PubMed ID: 8447406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of peripheral and central catecholaminergic and cholinergic mechanisms in the cardiovascular effects of thyrotropin-releasing hormone.
    Nurminen ML; Paakkari I
    Neuropeptides; 1991 Dec; 20(4):247-53. PubMed ID: 1667428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
    Helke CJ; Phillips ET
    J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sympatho-adrenal medullary functions in response to intracerebroventricularly injected corticotropin-releasing factor in anesthetized rats.
    Kurosawa M; Sato A; Swenson RS; Takahashi Y
    Brain Res; 1986 Mar; 367(1-2):250-7. PubMed ID: 3486023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain nuclear factor kappa B is involved in the corticotropin-releasing factor-induced central activation of sympatho-adrenomedullary outflow in rats.
    Okada S; Yamaguchi-Shima N; Shimizu T; Arai J; Yorimitsu M; Yokotani K
    Eur J Pharmacol; 2008 Apr; 584(1):207-12. PubMed ID: 18304530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance to nicotine-induced sympathoadrenal stimulation and cross-tolerance to stress: differential central and peripheral mechanisms in rats.
    Kiritsy-Roy JA; Mousa SA; Appel NM; Van Loon GR
    Neuropharmacology; 1990 Jun; 29(6):579-89. PubMed ID: 2385330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.